Terms: = Testicular cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Clinical Outcome
59 results:
1. Prognostic factors for relapse in patients with clinical stage I testicular non-seminoma: A nationwide, population-based cohort study.
Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Carus A; Rosenvilde JJ; Berney D; Daugaard G
Eur J Cancer; 2024 May; 202():114025. PubMed ID: 38531266
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic Factors for Relapse in Patients With clinical Stage I testicular Seminoma: A Nationwide, Population-Based Cohort Study.
Wagner T; Toft BG; Lauritsen J; Bandak M; Christensen IJ; Engvad B; Kreiberg M; Agerbæk M; Dysager L; Rosenvilde JJ; Berney D; Daugaard G
J Clin Oncol; 2024 Jan; 42(1):81-89. PubMed ID: 37683134
[TBL] [Abstract] [Full Text] [Related]
3. Malignant germ cell tumors in men aged 50 years and over are associated with adverse pathologic features and higher stage at presentation.
Almutairi F; Geisler D; Rammal R; Korentzelos D; Bastacky S; Dhir R; Bhattu A; Quiroga-Garza GM
Ann Diagn Pathol; 2023 Feb; 62():152070. PubMed ID: 36495736
[TBL] [Abstract] [Full Text] [Related]
4. Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor outcome in Male Malignant Germ Cell Tumors.
Timmerman DM; Eleveld TF; Sriram S; Dorssers LCJ; Gillis AJM; Schmidtova S; Kalavska K; van de Werken HJG; Oing C; Honecker F; Mego M; Looijenga LHJ
J Clin Oncol; 2022 Sep; 40(26):3077-3087. PubMed ID: 35442716
[TBL] [Abstract] [Full Text] [Related]
5. Somatic-type Malignancies in testicular Germ Cell Tumors: A Clinicopathologic Study of 63 Cases.
Hwang MJ; Hamza A; Zhang M; Tu SM; Pisters LL; Czerniak B; Guo CC
Am J Surg Pathol; 2022 Jan; 46(1):11-17. PubMed ID: 34334690
[TBL] [Abstract] [Full Text] [Related]
6. clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor.
Blok JM; van der Poel HG; Kerst JM; Bex A; Brouwer OR; Bosch JLHR; Horenblas S; Meijer RP
World J Urol; 2021 Jun; 39(6):1969-1976. PubMed ID: 32955662
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study.
Wagner T; Toft BG; Engvad B; Lauritsen J; Kreiberg M; Bandak M; Rosenvilde J; Christensen IJ; Pilt AP; Berney D; Daugaard G
BMJ Open; 2019 Oct; 9(10):e033713. PubMed ID: 31676661
[TBL] [Abstract] [Full Text] [Related]
8. Genomic Features of Metastatic testicular Sex Cord Stromal Tumors.
Necchi A; Bratslavsky G; Shapiro O; Elvin JA; Vergilio JA; Killian JK; Ngo N; Ramkissoon S; Severson E; Hemmerich AC; Ali SM; Chung JH; Reddy P; Miller VA; Schrock AB; Gay LM; Ross JS; Jacob JM
Eur Urol Focus; 2019 Sep; 5(5):748-755. PubMed ID: 31147264
[TBL] [Abstract] [Full Text] [Related]
9. Genomic Characterization of testicular Germ Cell Tumors Relapsing After Chemotherapy.
Necchi A; Bratslavsky G; Corona RJ; Chung JH; Millis SZ; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Severson E; Daniel S; Killian JK; Ali SM; Schrock AB; Reddy P; Miller VA; Welsh A; Gay LM; Ross JS
Eur Urol Focus; 2020 Jan; 6(1):122-130. PubMed ID: 30025711
[TBL] [Abstract] [Full Text] [Related]
10. clinical outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.
Dowling CM; Assel M; Musser JE; Meeks JJ; Sjoberg DD; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
Urology; 2018 Apr; 114():133-138. PubMed ID: 29410311
[TBL] [Abstract] [Full Text] [Related]
11. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors.
Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ
Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526
[TBL] [Abstract] [Full Text] [Related]
12. testicular seminoma: Are clinical features and treatment outcomes any different in India?
Anjanappa M; Kumar A; Mathews S; Joseph J; Jagathnathkrishna KM; James FV
Indian J Cancer; 2017; 54(1):385-387. PubMed ID: 29199728
[TBL] [Abstract] [Full Text] [Related]
13. [clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
14. Differences in global DNA methylation of testicular seminoma are not associated with changes in histone modifications, clinical prognosis, BRAF mutations or gene expression.
Pedersen LH; Nielsen JE; Daugaard G; Hansen TV; Rajpert-De Meyts E; Almstrup K
Cancer Genet; 2016 Nov; 209(11):506-514. PubMed ID: 27886677
[TBL] [Abstract] [Full Text] [Related]
15. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis.
Bilen MA; Hess KR; Campbell MT; Wang J; Broaddus RR; Karam JA; Ward JF; Wood CG; Choi SL; Rao P; Zhang M; Naing A; General R; Cauley DH; Lin SH; Logothetis CJ; Pisters LL; Tu SM
Oncotarget; 2016 Dec; 7(52):86280-86289. PubMed ID: 27861143
[TBL] [Abstract] [Full Text] [Related]
16. clinical outcome of Patients with Fibrosis/Necrosis at Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Advanced Germ Cell Tumors.
Mano R; Becerra MF; Carver BS; Bosl GJ; Motzer RJ; Bajorin DF; Feldman DR; Sheinfeld J
J Urol; 2017 Feb; 197(2):391-397. PubMed ID: 27720783
[TBL] [Abstract] [Full Text] [Related]
17. Pelvic Lymph Node Dissection in Patients Treated for Testis cancer: The Memorial Sloan Kettering cancer Center Experience.
Alanee SR; Carver BS; Feldman DR; Motzer RJ; Bosl GJ; Sheinfeld J
Urology; 2016 Sep; 95():128-31. PubMed ID: 27235751
[TBL] [Abstract] [Full Text] [Related]
18. Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer.
Tu SM; Bilen MA; Hess KR; Broaddus RR; Kopetz S; Wei C; Pagliaro LC; Karam JA; Ward JF; Wood CG; Rao P; Tu ZH; General R; Chen AH; Nieto YL; Yeung SC; Lin SH; Logothetis CJ; Pisters LL
Cancer; 2016 Jun; 122(12):1836-43. PubMed ID: 27018785
[TBL] [Abstract] [Full Text] [Related]
19. The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus.
Kilic E; Tennstedt P; Högner A; Lebok P; Sauter G; Bokemeyer C; Izbicki JR; Wilczak W
Virchows Arch; 2016 Apr; 468(4):483-92. PubMed ID: 26818834
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.
Cierna Z; Mego M; Miskovska V; Machalekova K; Chovanec M; Svetlovska D; Hainova K; Rejlekova K; Macak D; Spanik S; Ondrus D; Kajo K; Mardiak J; Babal P
Ann Oncol; 2016 Feb; 27(2):300-5. PubMed ID: 26598537
[TBL] [Abstract] [Full Text] [Related]
[Next]
